These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11747267)

  • 1. Characterization of disseminated tumor cells.
    Hosch SB; Braun S; Pantel K
    Semin Surg Oncol; 2001 Jun; 20(4):265-71. PubMed ID: 11747267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological characteristics of micrometastatic cancer cells in bone marrow.
    Braun S; Pantel K
    Cancer Metastasis Rev; 1999; 18(1):75-90. PubMed ID: 10505547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of occult metastatic tumor cells in bone marrow.
    Pantel K; Braun S
    Clin Breast Cancer; 2001 Oct; 2(3):222-8. PubMed ID: 11899416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
    Diel IJ; Cote RJ
    Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Micrometastatic cells in the bone marrow of patients with breast carcinoma].
    Diel IJ; Solomayer EF; Bastert G
    Radiologe; 2000 Aug; 40(8):681-7. PubMed ID: 11006937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
    Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
    Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micrometastases: marker of metastatic potential or evidence of residual disease?
    O'Sullivan GC; Collins JK; Kelly J; Morgan J; Madden M; Shanahan F
    Gut; 1997 Apr; 40(4):512-5. PubMed ID: 9176080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
    Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
    Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
    Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
    J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined sentinel lymph-node mapping and bone-marrow micrometastatic analysis for improved staging in breast cancer.
    Relihan N; McGreal G; Kelly J; Ryan D; O'Sullivan GC; Redmond HP
    Lancet; 1999 Jul; 354(9173):129-30. PubMed ID: 10408494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simultaneous immunocytochemical detection of tumor cells in lymph nodes and in bone marrow of patients with resectable bronchial carcinomas].
    Passlick B; Pantel K; Kubuschok B; Izbicki JR; Thetter O
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):21-4. PubMed ID: 14518204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow micrometastases and adjuvant treatment of breast cancer.
    Yu JJ; Brennan M; Christos P; Osborne MP; Hoda S; Simmons RM
    Breast J; 2004; 10(3):181-5. PubMed ID: 15125741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult metastases in patients with breast cancer.
    Hawes D; Neville AM; Cote RJ
    Ann Surg Oncol; 2001 Oct; 8(9 Suppl):60S-63S. PubMed ID: 11599903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Axillary lymph node and bone marrow micrometastases of breast cancer].
    Nahon S; Brewer Y; Kirscher S; Chauvet B; Berger C; Serin D
    Bull Cancer; 2001 Nov; 88(11):1095-104. PubMed ID: 11741804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Micrometastases in pediatric oncology].
    Bernard F; Aerts I; Margueritte G; Astruc J
    Bull Cancer; 2001 Jun; 88(6):577-80. PubMed ID: 11459704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer.
    Bjørnland K; Flatmark K; Mala T; Mathisen O; Bakka A; Aasen AO; Bergan A; Søreide O; Fodstad O
    J Surg Oncol; 2003 Apr; 82(4):224-7. PubMed ID: 12672004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.
    Braun S; Cevatli BS; Assemi C; Janni W; Kentenich CR; Schindlbeck C; Rjosk D; Hepp F
    J Clin Oncol; 2001 Mar; 19(5):1468-75. PubMed ID: 11230493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of occult metastatic cells in bone marrow of breast cancer patients.
    Braun S; Pantel K
    Oncologist; 2001; 6(2):125-32. PubMed ID: 11306724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow.
    Weitz J; Kienle P; Magener A; Koch M; Schrödel A; Willeke F; Autschbach F; Lacroix J; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Clin Cancer Res; 1999 Jul; 5(7):1830-6. PubMed ID: 10430088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Minimal residual disease in gastrointestinal tumors: tumor detection in bone marrow, blood and lymph nodes].
    Rosenberg R; Nekarda H; Thorban S; Siewert JR
    Acta Med Austriaca Suppl; 2002; 59():42-53. PubMed ID: 12506760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.